Applied Therapeutics Cash from Financing (Quarterly) Trends

Applied Therapeutics Inc (APLT)

9.625 +0.36 (+3.83%) USD | NASDAQ | Nov 22, 16:00

9.39 -0.24 (-2.44%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	0.00
June 30, 2024	-1.692M
March 31, 2024	115.50M
December 31, 2023	29.45M
September 30, 2023	16.57M
June 30, 2023	29.15M
March 31, 2023	-0.622M
December 31, 2022	-0.933M
September 30, 2022	-0.971M
June 30, 2022	30.38M
March 31, 2022	-0.789M
December 31, 2021	-1.184M
September 30, 2021	-1.08M
June 30, 2021	3.495M

Date	Value
March 31, 2021	73.49M
December 31, 2020	3.093M
September 30, 2020	-1.236M
June 30, 2020	0.218M
March 31, 2020	134.22M
December 31, 2019	18.32M
September 30, 2019	-0.294M
June 30, 2019	35.45M
March 31, 2019	2.94M
December 31, 2018	21.06M
September 30, 2018	0.028M
June 30, 2018	0.009M
March 31, 2018	5.56M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.692M

Minimum

Jun 2024

134.22M

Maximum

Mar 2020

22.27M

Average

1.656M

Median

Cash from Financing (Quarterly) Benchmarks

ResMed Inc	-150.76M
Axonics Inc	2.525M
Organon & Co	-78.00M
NovaBay Pharmaceuticals Inc	2.089M
Palatin Technologies Inc	-0.127M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-23.33M
Free Cash Flow	-81.84M
Free Cash Flow Per Share (Quarterly)	-0.1616
Free Cash Flow to Equity (Quarterly)	-23.33M
Free Cash Flow Yield	-6.39%